NYSE:RFL Rafael (RFL) Stock Price, News & Analysis → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free RFL Stock Alerts $1.71 -0.03 (-1.72%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$1.65▼$1.7750-Day Range$1.66▼$1.9152-Week Range$1.44▼$2.52Volume8,463 shsAverage Volume17,511 shsMarket Capitalization$42.03 millionP/E Ratio17.10Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Rafael alerts: Email Address Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. About Rafael Stock (NYSE:RFL)Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.Read More RFL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RFL Stock News HeadlinesApril 23, 2024 | msn.comRafael Devers injury return date will relieve Red Sox fansApril 23, 2024 | msn.comNo Rafael Devers Again On TuesdayApril 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...April 23, 2024 | msn.comRafael Nadal and Roger Federer towards the same touching fateApril 23, 2024 | sportsbookwire.usatoday.comRafael Nadal: Mutua Madrid Open Betting Odds and PreviewApril 23, 2024 | msn.comRed Sox lineup: Alex Cora explains why Rafael Devers, Masataka Yoshida are outApril 23, 2024 | finance.yahoo.comMadison Group Announces Plans for Master-Planned Community on Eglinton Ave. East By World-Renowned Rafael Viñoly ArchitectsApril 23, 2024 | forbes.comNovak Djokovic ‘Hopes To Play Rafael Nadal At Least One More Time Before He Retires’April 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...April 23, 2024 | msn.comFans crazy for Roddick's bold prediction on Rafael Nadal!April 23, 2024 | msn.comRafael Nadal's Laver Cup Odyssey Echoes Roger Federer's FarewellApril 22, 2024 | msn.comCould Mexico's Rafael Márquez really be Xavi Hernández 's successor at Barcelona?April 22, 2024 | msn.comRafael Nadal returns to Laver Cup!April 22, 2024 | sportsbookwire.usatoday.comMutua Madrid Open: Darwin Blanch vs. Rafael Nadal Betting Odds and Match PreviewApril 22, 2024 | msn.comRafael Devers, Tyler O’Neill inching closer to playing again for the Red SoxApril 22, 2024 | msn.comRafael Nadal registers for 2024 Laver Cup in BerlinApril 22, 2024 | msn.comRafael Nadal reveals his dream to pursue before retiringApril 20, 2024 | msn.comRed Sox’ Alex Cora reveals return timetables for Rafael Devers, Nick PivettaApril 20, 2024 | msn.comRed Sox’ Rafael Devers missing for ninth time in 22 games Saturday vs. PiratesApril 20, 2024 | msn.comEditorial: San Rafael needs agreement with encampment residentsApril 20, 2024 | msn.comSan Rafael traffic project to relieve persistent clotApril 19, 2024 | msn.comRafael Devers (knee) out of Red Sox lineup again but club has ruled out ILApril 19, 2024 | msn.com‘Built for sustainable success’: Rafael Stone reacts to new contract with RocketsApril 19, 2024 | msn.comRed Sox lineups: Rafael Devers sits out Pirates series opener, but won’t go on injured listApril 18, 2024 | msn.comRed Sox third baseman Rafael Devers has a bone bruise in his sore left kneeApril 18, 2024 | msn.comRed Sox’ Rafael Devers ‘not going to rush’ back from bone bruiseApril 18, 2024 | msn.comSeeking ‘peace of mind,’ Rafael Devers to undergo MRI on ailing left kneeSee More Headlines Receive RFL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rafael and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today4/24/2024Next Earnings (Estimated)6/11/2024Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Real estate Sub-IndustryN/A Current SymbolNYSE:RFL CUSIPN/A CIK1713863 Webwww.rafaelholdings.com Phone(212) 658-1450FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.10 Trailing P/E Ratio17.10 Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,880,000.00 Net Margins776.36% Pretax Margin827.64% Return on Equity-4.31% Return on Assets-4.22% Debt Debt-to-Equity RatioN/A Current Ratio23.01 Quick Ratio23.01 Sales & Book Value Annual Sales$280,000.00 Price / Sales150.11 Cash FlowN/A Price / Cash FlowN/A Book Value$3.98 per share Price / Book0.43Miscellaneous Outstanding Shares24,580,000Free Float22,199,000Market Cap$42.03 million OptionableOptionable Beta1.32 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Howard S. Jonas (Age 68)Founder & Executive Chairman Comp: $40kMr. William Conkling (Age 52)CEO & President Comp: $751.95kMr. David A. Polinsky Esq. (Age 52)Chief Financial Officer Comp: $363.3kMs. Barbara A. Ryan (Age 64)Investor Relations Officer Mr. Gus KodershaChief Technical Operations OfficerDr. Rick EwingHead of Drug DiscoveryDr. John Mayer Goldberg M.D. (Age 51)Chief Medical Officer Ms. Joyce J. Mason Esq. (Age 65)Corporate Secretary More ExecutivesKey CompetitorsAspira Women's HealthNASDAQ:AWHNKGen BiotechNYSE:NKGNPrenetics GlobalNASDAQ:PREBolt BiotherapeuticsNASDAQ:BOLTCarmellNASDAQ:CTCXView All CompetitorsInstitutional OwnershipAcuitas Investments LLCBought 88,940 shares on 2/2/2024Ownership: 1.315%Simplex Trading LLCBought 2,500 shares on 2/2/2024Ownership: 0.000%View All Institutional Transactions RFL Stock Analysis - Frequently Asked Questions How have RFL shares performed in 2024? Rafael's stock was trading at $1.83 at the beginning of 2024. Since then, RFL stock has decreased by 6.6% and is now trading at $1.71. View the best growth stocks for 2024 here. Are investors shorting Rafael? Rafael saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 38,800 shares, a decrease of 36.0% from the March 15th total of 60,600 shares. Based on an average daily trading volume, of 26,500 shares, the short-interest ratio is currently 1.5 days. View Rafael's Short Interest. When is Rafael's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024. View our RFL earnings forecast. How were Rafael's earnings last quarter? Rafael Holdings, Inc. (NYSE:RFL) released its earnings results on Wednesday, March, 13th. The company reported ($0.08) earnings per share for the quarter. The company had revenue of $0.07 million for the quarter. Rafael had a net margin of 776.36% and a negative trailing twelve-month return on equity of 4.31%. How do I buy shares of Rafael? Shares of RFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RFL) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rafael Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
